InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Explore the complete record of transactions filed by Shetzline Michael, CMO, SVP & Responsable du Développement Médical. Officer active across 1 companies, notably Ironwood Pharmaceuticals INC. Cumulatively, 9 filings have been published. Total volume traded: €372k. The latest transaction was filed on 23 May 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
€33,6973,130 shares@ €10.76570.0057% mcap9.1% of flow
Class A Common Stock
SEC:0001209191-22-031842:0·
081,448 shares0
Class A Common Stock
SEC:0001209191-22-016184:0·
€13,1671,367 shares@ €9.63240.0022% mcap3.5% of flow
Class A Common Stock
SEC:0001209191-22-014652:0·
029,326 shares0
Class A Common Stock
SEC:0001104659-22-006551·
029,326 shares0
Class A Common Stock
SEC:0001104659-22-006551:0·
€141,90013,776 shares@ €10.30050.024% mcap87.2% of flow
Class A Common Stock
SEC:0001209191-21-066780·
€141,90013,776 shares@ €10.30050.024% mcap38.1% of flow
Class A Common Stock
SEC:0001209191-21-066780:0·
€20,8302,077 shares@ €10.0290.0035% mcap12.8% of flow
Class A Common Stock
SEC:0001209191-21-035905·
€20,8302,077 shares@ €10.0290.0035% mcap5.6% of flow
Class A Common Stock
SEC:0001209191-21-035905:0·
9 of 9 declarations
About Shetzline Michael
Michael Shetzline is the CMO, Senior Vice President, and Head of Drug Development at Ironwood Pharmaceuticals Inc. He oversees drug development initiatives, focusing on innovation and efficiency. His expertise in the pharmaceutical field is crucial for the success of the company's research and development projects.
